{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:06:00Z","timestamp":1783998360649,"version":"3.55.0"},"reference-count":62,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibodies"],"abstract":"<jats:p>Human Papillomavirus (HPV) infection is the leading cause of cervical cancer, presenting a significant global health challenge. While natural infection is widespread, the resulting immune response is often characterized by weak, delayed, and type-specific antibody production, offering unreliable protection against reinfection. This review provides a comparative analysis of natural versus vaccine-induced immunity, focusing on antibody kinetics, duration of protection, and cancer prevention efficacy. A comprehensive search of the literature from the last decade was conducted using PubMed, ScienceDirect, and Web of Science. The findings demonstrate that, unlike natural immunity, which is dominated by cellular responses with often incomplete seroconversion, prophylactic vaccination induces high titers of neutralizing IgG antibodies against the L1 capsid protein. These responses are durable, with protection persisting for over a decade, and recent data support the high efficacy of single-dose regimens. Furthermore, vaccination has shown utility in reducing infection persistence in HPV-positive individuals and provides critical protection in immunocompromised groups. Consequently, vaccine-induced immunity is consistently superior to naturally acquired immunity, supporting World Health Organization recommendations for universal vaccination as the primary intervention for reducing the global burden of HPV-related malignancies.<\/jats:p>","DOI":"10.3390\/antib15040061","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:34:44Z","timestamp":1783996484000},"page":"61","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Natural Versus Vaccine-Induced Immunity Against HPV: A Comparative Review of Antibody Response and Cancer Prevention"],"prefix":"10.3390","volume":"15","author":[{"given":"Bogdan","family":"Ghilencea","sequence":"first","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050471 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Ilinca","family":"Moroianu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050471 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8970-8863","authenticated-orcid":false,"given":"Ancu\u021ba-Iuliana","family":"N\u0103stac","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050471 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana-Stefania","family":"Bostan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050471 Bucharest, Romania"},{"name":"Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9213-6735","authenticated-orcid":false,"given":"Anca","family":"Panaitescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050471 Bucharest, Romania"},{"name":"Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mehedin\u021bu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050471 Bucharest, Romania"},{"name":"Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8425-6307","authenticated-orcid":false,"given":"Nicolae","family":"Gic\u0103","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050471 Bucharest, Romania"},{"name":"Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/21645515.2018.1512453","article-title":"Disparities in HPV Vaccination Rates and HPV Prevalence in the United States: A Review of the Literature","volume":"15","author":"Hirth","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Milano, G., Guarducci, G., Nante, N., Montomoli, E., and Manini, I. (2023). Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?. Vaccines, 11.","DOI":"10.20944\/preprints202304.0542.v1"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ijc.31819","article-title":"HPV-mRNA and HPV-DNA Detection in Samples Taken up to Seven Years before Severe Dysplasia of Cervix Uteri","volume":"144","author":"Forslund","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13027-018-0178-5","article-title":"Prevalence of Human Papillomavirus Infection among Iranian Women Using COBAS HPV DNA Testing","volume":"13","author":"Jamdar","year":"2018","journal-title":"Infect. Agents Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-023-00628-8","article-title":"Differences in HPV-Specific Antibody Fc-Effector Functions Following Gardasil\u00ae and Cervarix\u00ae Vaccination","volume":"8","author":"Roy","year":"2023","journal-title":"npj Vaccines"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"127857","DOI":"10.1016\/j.micres.2024.127857","article-title":"Cervicovaginal Microbiome, High-Risk HPV Infection and Cervical Cancer: Mechanisms and Therapeutic Potential","volume":"287","author":"Huang","year":"2024","journal-title":"Microbiol. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Kiamba, E.W., Goodier, M.R., and Clarke, E. (2025). Immune Responses to Human Papillomavirus Infection and Vaccination. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1591297"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Di Spirito, F., Pantaleo, G., Di Palo, M.P., Amato, A., Raimondo, A., and Amato, M. (2023). Oral Human Papillomavirus Benign Lesions and HPV-Related Cancer in Healthy Children: A Systematic Review. Cancers, 15.","DOI":"10.3390\/cancers15041096"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal Attribution of Human Papillomavirus Genotypes to Invasive Cervical Cancer Worldwide: A Systematic Analysis of the Global Literature","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"28217","DOI":"10.1038\/s41598-025-14228-0","article-title":"High-Risk Human Papillomavirus Genotype Distribution and Attribution to Cervical Lesions in a Shanxi Province Screening Population","volume":"15","author":"Shi","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mirabello, L., Clarke, M., Nelson, C., Dean, M., Wentzensen, N., Yeager, M., Cullen, M., Boland, J., Schiffman, M., and Burk, R. (2018). The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis. Viruses, 10.","DOI":"10.3390\/v10020080"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Santacroce, L., Di Cosola, M., Bottalico, L., Topi, S., Charitos, I.A., Ballini, A., Inchingolo, F., Cazzolla, A.P., and Dipalma, G. (2021). Focus on HPV Infection and the Molecular Mechanisms of Oral Carcinogenesis. Viruses, 13.","DOI":"10.3390\/v13040559"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The Natural History of Human Papillomavirus Infection","volume":"47","author":"Brotons","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1158\/1055-9965.EPI-17-0853","article-title":"An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study","volume":"27","author":"Beachler","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/infdis\/jiu143","article-title":"Naturally Acquired Immunity Against Human Papillomavirus (HPV): Why It Matters in the HPV Vaccine Era","volume":"210","author":"Franceschi","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1002\/cam4.1879","article-title":"Risk of Newly Detected Infections and Cervical Abnormalities in Adult Women Seropositive or Seronegative for Naturally Acquired HPV-16\/18 Antibodies","volume":"8","author":"Rosillon","year":"2019","journal-title":"Cancer Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2217\/fmb-2021-0221","article-title":"Comparison of HPV Neutralizing and IgG Antibodies in Unvaccinated Female Adolescents","volume":"17","author":"Yao","year":"2022","journal-title":"Future Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/infdis\/jiac437","article-title":"Serologic Response to Human Papillomavirus Genotypes among Unvaccinated Women: Findings from the HITCH Cohort Study","volume":"227","author":"Morais","year":"2023","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/s41598-022-06343-z","article-title":"Maternal HPV-Antibodies and Seroconversion to HPV in Children during the First 3 Years of Life","volume":"12","author":"Waterboer","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S1470-2045(20)30524-6","article-title":"Efficacy of the Bivalent HPV Vaccine against HPV 16\/18-Associated Precancer: Long-Term Follow-up Results from the Costa Rica Vaccine Trial","volume":"21","author":"Porras","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1016\/S2214-109X(22)00309-6","article-title":"Immunogenicity and Safety of One-Dose Human Papillomavirus Vaccine Compared with Two or Three Doses in Tanzanian Girls (DoRIS): An Open-Label, Randomised, Non-Inferiority Trial","volume":"10","author":"Changalucha","year":"2022","journal-title":"Lancet Glob. Health"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.vaccine.2022.11.057","article-title":"High Vaccine Effectiveness Persists for Ten Years after HPV16\/18 Vaccination among Young Dutch Women","volume":"41","author":"Hoes","year":"2023","journal-title":"Vaccine"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pruski, D., \u0141agiedo-\u017celazowska, M., Millert-Kali\u0144ska, S., Sikora, J., Jach, R., and Przybylski, M. (2022). Immunity after HPV Vaccination in Patients after Sexual Initiation. Vaccines, 10.","DOI":"10.3390\/vaccines10050728"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"ofaf218","DOI":"10.1093\/ofid\/ofaf218","article-title":"Serosurveillance to Support HPV Vaccination in England","volume":"12","author":"Panwar","year":"2025","journal-title":"Open Forum Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Steinberg, J., Panicker, G., Unger, E.R., Blake, I., Lewis, R.M., Geis, J., Bruden, D., Fischer, M., Markowitz, L.E., and Bruce, M.G. (2025). Immunogenicity and Duration of Antibodies after Vaccination with a Two-Dose Series of the Nine-Valent Human Papillomavirus Vaccine among Alaska Native Children: A Prospective Cohort Study. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-10961-z"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/cncr.34783","article-title":"Prevalence of Oral and Blood Oncogenic Human Papillomavirus Biomarkers among an Enriched Screening Population: Baseline Results of the MOUTH Study","volume":"129","author":"Tewari","year":"2023","journal-title":"Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e2022060993","DOI":"10.1542\/peds.2022-060993","article-title":"Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety","volume":"152","author":"Restrepo","year":"2023","journal-title":"Pediatrics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2078626","DOI":"10.1080\/21645515.2022.2078626","article-title":"Effectiveness, Immunogenicity, and Safety of the Quadrivalent HPV Vaccine in Women and Men Aged 27\u201345 Years","volume":"18","author":"Maldonado","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"EVIDoa2100056","DOI":"10.1056\/EVIDoa2100056","article-title":"Efficacy of single-dose HPV vaccination among young African women","volume":"1","author":"Barnabas","year":"2022","journal-title":"NEJM Evid."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Pruski, D., Millert-Kali\u0144ska, S., \u0141agiedo, M., Sikora, J., Jach, R., and Przybylski, M. (2023). Effect of HPV Vaccination on Virus Disappearance in Cervical Samples of a Cohort of HPV-Positive Polish Patients. J. Clin. Med., 12.","DOI":"10.3390\/jcm12247592"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e14476","DOI":"10.1111\/petr.14476","article-title":"Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in Pediatric Kidney and Liver Transplant Recipients","volume":"27","author":"Kitano","year":"2023","journal-title":"Pediatr. Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Weissert, R., Mehta, T., Kammeyer, R., Xie, C., Li, A., Hu, Y., Li, J., Chen, X., and Jiang, Y. (2022). Case Report: Anti-GAD65 Antibody-Associated Autoimmune Encephalitis Following HPV Vaccination. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.1017086"},{"key":"ref_33","first-page":"2313","article-title":"Immune Response to Human Papillomavirus One Year after Prophylactic Vaccination with AS04-Adjuvanted HPV-16\/18 Vaccine: HPV-Specific IgG and IgA Antibodies in the Circulation and the Cervix","volume":"19","author":"Costa","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/ijgc-2019-000582","article-title":"Human Papillomavirus (HPV) Vaccination: From Clinical Studies to Immunization Programs","volume":"29","author":"Murillo","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/jnci\/djaa010","article-title":"Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial","volume":"112","author":"Tsang","year":"2020","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cheng, L., Wang, Y., and Du, J. (2020). Human Papillomavirus Vaccines: An Updated Review. Vaccines, 8.","DOI":"10.3390\/vaccines8030391"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.omto.2021.07.006","article-title":"Prognostic and Therapeutic TILs of Cervical Cancer\u2014Current Advances and Future Perspectives","volume":"22","author":"Tang","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Tessandier, N., Elie, B., Bou\u00e9, V., Selinger, C., Rahmoun, M., Bernat, C., Grasset, S., Groc, S., Bedin, A.S., and Beneteau, T. (2025). Viral and Immune Dynamics of Genital Human Papillomavirus Infections in Young Women with High Temporal Resolution. PLoS Biol., 23.","DOI":"10.1371\/journal.pbio.3002949"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/s41467-025-57443-z","article-title":"Systems Serology Analysis Shows IgG1 and IgG3 Memory Responses Six Years after One Dose of Quadrivalent HPV Vaccine","volume":"16","author":"Quang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00405-024-08537-9","article-title":"Detection of Antibody Subclasses IgA, IgM and IgG against HPV L1 in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Patients: A Pilot Study","volume":"281","author":"Weiland","year":"2024","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/21645515.2019.1669413","article-title":"Priming Effect of Bivalent and Quadrivalent Vaccine for HPV 31\/33\/45\/52: An Exploratory Analysis from Two Clinical Trials","volume":"16","author":"Sauvageau","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e087326","DOI":"10.1136\/bmj-2025-087326","article-title":"Extended Follow-up of Invasive Cervical Cancer Risk after Quadrivalent HPV Vaccination: Nationwide, Register Based Study","volume":"392","author":"Wu","year":"2026","journal-title":"BMJ"},{"key":"ref_44","first-page":"16086","article-title":"Carcinogenic Human Papillomavirus Infection","volume":"2","author":"Schiffman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrmicro2872","article-title":"Understanding and Learning from the Success of Prophylactic Human Papillomavirus Vaccines","volume":"10","author":"Schiller","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Pasmans, H., Berkowska, M.A., Diks, A.M., de Mooij, B., Groenland, R.J., de Rond, L., Nicolaie, M.A., van der Burg, S.H., van Dongen, J.J.M., and van der Klis, F.R.M. (2022). Characterization of the Early Cellular Immune Response Induced by HPV Vaccines. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.863164"},{"key":"ref_47","unstructured":"Centers for Disease Control and Prevention (CDC) (2026, July 07). HPV Vaccination Considerations: Safety and Effectiveness Data, Available online: https:\/\/www.cdc.gov\/hpv\/hcp\/vaccination-considerations\/safety-and-effectiveness-data.html."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S1473-3099(25)00284-1","article-title":"Human Papillomavirus (HPV) Type 16 and Type 18 Antibody Concentrations after a Single Dose of Bivalent HPV Vaccine in Girls Aged 9\u201314 Years Compared with Three Doses of Quadrivalent HPV Vaccine in Women Aged 18\u201325 Years in Costa Rica (PRIMAVERA): A Non-Randomised, Open-Label, Immunobridging, Non-Inferiority Trial","volume":"25","author":"Ocampo","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.vaccine.2022.11.044","article-title":"Evaluation of Immune Response to Single Dose of Quadrivalent HPV Vaccine at 10-Year Post-Vaccination","volume":"41","author":"Joshi","year":"2023","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1056\/NEJMoa2506765","article-title":"Noninferiority of One HPV Vaccine Dose to Two Doses","volume":"393","author":"Kreimer","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4161\/hv.22693","article-title":"Detection of Systemic and Mucosal HPV-Specific IgG and IgA Antibodies in Adolescent Girls One and Two Years after HPV Vaccination","volume":"9","author":"Scherpenisse","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/bjc.2015.462","article-title":"Human Papillomavirus Vaccination Induces Neutralising Antibodies in Oral Mucosal Fluids","volume":"114","author":"Handisurya","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Wu, Z., Li, X., and Zhang, B. (2025). Assessment of the Ability of HPV Vaccines to Induce Neutralizing Antibodies Based on Pseudovirus-Based Neutralization Assay. Front. Public Health, 13.","DOI":"10.3389\/fpubh.2025.1636491"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Middeldorp, M., Duijster, J.W., van de Kassteele, J., van der Klis, F.R.M., and de Melker, H.E. (2024). Immune Response Following a Two-Dose Schedule of Bivalent HPV Vaccination among Girls and Boys. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1327770"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"127475","DOI":"10.1016\/j.vaccine.2025.127475","article-title":"Immune Response after One Dose of HPV Vaccine among Girls and Boys and the Impact of a Second Dose given after 3 or More Years","volume":"62","author":"Guzun","year":"2025","journal-title":"Vaccine"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1016\/j.vaccine.2017.07.017","article-title":"Antibody Persistence and Evidence of Immune Memory at 5 Years Following Administration of the 9-Valent HPV Vaccine","volume":"35","author":"Guevara","year":"2017","journal-title":"Vaccine"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Ewaisha, R., Ruffin, M.T., Williams, S., Chung, Y., DeGraffinreid, C.R., Paskett, E.D., Reiter, P.L., Qiu, J., Brenner, D.E., and Anderson, K.S. (2025). Serum Profiling of the Antibody Response to HPV in Women with or without Abnormal Cervical Cytology Undergoing Cervical Cancer Screening. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1612761"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Mauz, P.S., Sch\u00e4fer, F.A., Iftner, T., and Gonser, P. (2018). HPV Vaccination as Preventive Approach for Recurrent Respiratory Papillomatosis\u2014A 22-Year Retrospective Clinical Analysis. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3260-0"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jamaoto.2022.1190","article-title":"Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis","volume":"148","author":"Smahelova","year":"2022","journal-title":"JAMA Otolaryngol.-Head Neck Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/ijc.35345","article-title":"Scientific Approaches to Defining HPV Vaccine-Induced Protective Immunity","volume":"156","author":"Lehtinen","year":"2025","journal-title":"Int. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.4161\/hv.34408","article-title":"Comparison of Adaptive and Innate Immune Responses Induced by Licensed Vaccines for Human Papillomavirus","volume":"10","author":"Herrin","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_62","first-page":"100220","article-title":"Potential Role of Naturally Acquired Immunity against HPV in the Control of HPV Related Diseases","volume":"13","author":"Tian","year":"2021","journal-title":"Lancet Reg. Health West. Pac."}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/15\/4\/61\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:48:57Z","timestamp":1783997337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/15\/4\/61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["antib15040061"],"URL":"https:\/\/doi.org\/10.3390\/antib15040061","relation":{},"ISSN":["2073-4468"],"issn-type":[{"value":"2073-4468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]}}}